World's Best Scientists 2026 revealed!
Philip S. Helliwell

Philip S. Helliwell

D-Index & Metrics

Medicine

D-Index
83
Citations
32242
World Ranking
15433
National Ranking
1419

Overview

Philip S. Helliwell is affiliated with the University of Leeds in the United Kingdom. Their research focuses primarily on Medicine and Immunology and Microbiology, with significant contributions in the subfields of Rheumatology, Immunology, Hematology, Economics and Econometrics, and Dermatology. The scientist's main research topics include Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis, Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research, Health Systems, Economic Evaluations, Quality of Life, Dermatology and Skin Diseases, and Osteomyelitis and Bone Disorders Research.

Helliwell has contributed extensively to academic literature, with a significant number of publications appearing in a range of specialist venues. Frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • The Journal of Rheumatology
  • RMD Open
  • Journal of the American Academy of Dermatology

The researcher has collaborated often with colleagues such as Laura C. Coates, Philip J. Mease, Dafna D. Gladman, Oliver FitzGerald, and A. Kollmeier.

Among recent papers associated with the scientist are:

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021, 2022, Nature Reviews Rheumatology
  • Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial, 2020, The Lancet
  • Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials, 2020, Annals of the Rheumatic Diseases
  • Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies, 2021, The Lancet Rheumatology
  • Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced, 2021, RMD Open

Best Publications

  • Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

    William Taylor;Dafna Gladman;Philip Helliwell;Antonio Marchesoni

  • Correction: Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis

    John Bowes;Ashley Budu-Aggrey;Ulrike Huffmeier;Steffen Uebe

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Josef S Smolen;Monika Schöls;Jürgen Braun;Maxime Dougados

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

  • Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment

    Laura C Coates;Jaap Fransen;Philip S Helliwell

  • Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

    L C Doward;A Spoorenberg;S A Cook;D Whalley

  • Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

    Josef S. Smolen;Jürgen Braun;Maxime Dougados;Paul Emery

  • European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

    L Gossec;J S Smolen;C Gaujoux-Viala;Z Ash

  • Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis.

    Paul J. Healy;Philip S. Helliwell

  • Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

    Laura C Coates;Anna R Moverley;Lucy McParland;Sarah Brown

  • A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    Laure Gossec;Maarten de Wit;Uta Kiltz;Juergen Braun

  • Classification and diagnostic criteria for psoriatic arthritis.

    P S Helliwell;W J Taylor

  • The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

    Philip S Helliwell;Philip S Helliwell;Oliver FitzGerald;Jaap Fransen;Dafna D Gladman

  • Consensus on a core set of domains for psoriatic arthritis

    Dafna D Gladman;Philip J Mease;Vibeke Strand;Paul Healy

  • Comparison of disability and quality of life in rheumatoid and psoriatic arthritis.

    Katharina B. Sokoll;Philip S. Helliwell

  • Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire.

    G H Ibrahim;M H Buch;C Lawson;R Waxman

  • A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

    Philip J Mease;Josef S Smolen;Frank Behrens;Peter Nash

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

    Laura C Coates;Oliver Fitzgerald;Joseph F Merola;Josef Smolen

Frequent Co-Authors

Philip J. Mease
Philip J. Mease University of Washington
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Oliver FitzGerald
Oliver FitzGerald University College Dublin
Neil McHugh
Neil McHugh University of Bath
Paul Emery
Paul Emery University of Leeds
Christopher T. Ritchlin
Christopher T. Ritchlin University of Rochester Medical Center
Arthur Kavanaugh
Arthur Kavanaugh University of California, San Diego
Dennis McGonagle
Dennis McGonagle University of Leeds
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Wolf-Henning Boehncke
Wolf-Henning Boehncke University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine isn’t the only path to a healthcare career in the USA—related online degrees can open doors to a variety of fast-growing fields. For those interested in pharmacy, recent innovations now make it possible to complete a 3 year online pharmd, blending flexible study with advanced clinical training.

Medical administration also offers a strong career outlook. Many students now pursue rhia certification programs online to qualify for roles managing health information systems and ensuring data accuracy.

For those seeking quick entry into healthcare, exploring the cheapest medical coding certification online can start your career in medical billing and coding—a vital function in hospitals and clinics.

Nursing remains a cornerstone of patient care, and students can advance their credentials through cheap online fnp programs to become family nurse practitioners. These online pathways make it easier for diverse students to access rewarding careers in healthcare beyond traditional medicine.

Best Scientists Citing Philip S. Helliwell

Trending Scientists

Recently Published Articles